Annals of Oncology

News:

For Germany, better late than never in biotech race
Ann Oncol 8: 1-2.
[PDF] [Request Permissions]

Car makers like tobacco producers?
Ann Oncol 8: 2.
[PDF] [Request Permissions]

Dispute over breast cancer research funds in the US
Ann Oncol 8: 2-3.
[PDF] [Request Permissions]

EU to support complementary medicine?
Ann Oncol 8: 3.
[PDF] [Request Permissions]

Rehearsal of the Nuremberg code
Ann Oncol 8: 3-4.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 8: 4-5.
[PDF] [Request Permissions]

Book reviews:

A. Fogliata-Cozzi and J. Bernier

Book review
Ann Oncol 8: 6.
[PDF] [Request Permissions]

Editorial:

F. Cavalli

Full speed ahead into our second period
Ann Oncol 8: 7.
[PDF] [Request Permissions]

Special articles:

P. Boyle

European Cancer Experts recommendations for tobacco control
Ann Oncol 8: 9-13.
[PDF] [Request Permissions]

Review:

J. Lokich and N. Anderson

Dose intensity for bolus versus infusion chemotherapy administration: Review of the literature for 27 anti-neoplastic agents
Ann Oncol 8: 15-25.
[Abstract] [PDF] [Request Permissions]

Commentary:

P. Bunn, D. Carbone, J. Grim, C. Harris, K. Havemann, M. Mabry, J. Roth, N. Saijo, H. Skovgaard Poulsen, R. Stahel, T. Takahashi, and P. Twentyman

Fifth I.A.S.L.C. Lung Tumor Biology Workshop, August 13–17, 1996, Ermatingen, Switzerland
Ann Oncol 8: 27-36.
[PDF] [Request Permissions]

Original articles:

A. Horwich, B. Paluchowska, A. Norman, R. Huddart, J. Nicholls, C. Fisher, J. Husband, and D. P. Dearnaley

Residual mass following chemotherapy of seminoma
Ann Oncol 8: 37-40.
[Abstract] [PDF] [Request Permissions]

A. Gerl, C. Clemm, N. Schmeller, M. Hentrich, R. Lamerz, and W. Wilmanns

Late relapse of germ cell tumors after cisplatin-based chemotherapy
Ann Oncol 8: 41-47.
[Abstract] [PDF] [Request Permissions]

S. Fetscher, W. Brugger, R. Engelhardt, L. Kanz, J. Hasse, H. Frommhold, M. Wenger, W. Lange, and R. Mertelsmann

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer
Ann Oncol 8: 49-56.
[Abstract] [PDF] [Request Permissions]

S. Fetscher, W. Brugger, R. Engelhardt, L. Kanz, J. Hasse, H. Frommhold, M. Wenger, W. Lange, and R. Mertelsmann

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer
Ann Oncol 8: 57-64.
[Abstract] [PDF] [Request Permissions]

J. Norum, B. Vonen, J. A. Olsen, and A. Revhaug

Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis
Ann Oncol 8: 65-70.
[Abstract] [PDF] [Request Permissions]

M. Hernberg, T. Muhonen, and S. Pyrhönen

Can the CD4+/CD8+ ratio predict the outcome of interferon- therapy for renal cell carcinoma?
Ann Oncol 8: 71-77.
[Abstract] [PDF] [Request Permissions]

A. Tulpule, B. Joshi, N. DeGuzman, B. M. Espina, R. Mocharnuk, O. Prakash, D. Templeton, A. M. Levine, and P. S. Gill

Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma
Ann Oncol 8: 79-83.
[Abstract] [PDF] [Request Permissions]

I. W. Dimery, W. K. Hong, J. J. Lee, C. Guillory-Perez, F. Pham, H. A. Fritsche, Jr., and S. M. Lippman

Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity
Ann Oncol 8: 85-89.
[Abstract] [PDF] [Request Permissions]

Clinical case:

A. Sureda and M. Hernández-Bronchud

The management of chronic myeloid leukaemia - a case history
Ann Oncol 8: 91-96.
[PDF] [Request Permissions]

Letters:

G. Masera and M. Jankovic

Tumor lysis syndrome, case report and review of the literature
Ann Oncol 8: 97.
[PDF] [Request Permissions]

P. C. Lorigan, P. L. Woodings, G. R. Morgenstern, and J. H. Scarffe

This letter was referred to the authors, who respond as follows:
Ann Oncol 8: 97.
[PDF] [Request Permissions]

Advertisements in this issue:

Rhôone-Poulenc Rorer (limited circulation)
Ann Oncol 8: 99.
[PDF] [Request Permissions]

Classified advertisements from ESMO members and meeting anouncements
Ann Oncol 8: 101.
[PDF] [Request Permissions]

Bristol-Meyers Squibb
Ann Oncol 8: 102.
[PDF] [Request Permissions]

ESMO applications for membership
Ann Oncol 8: 102.
[PDF] [Request Permissions]

Instructions to authors:

Instructions to authors
Ann Oncol 8: 99.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.